
1. Antonie Van Leeuwenhoek. 2020 Apr;113(4):589-592. doi:
10.1007/s10482-019-01353-w. Epub 2019 Nov 18.

Novel mutations in the QRDR region gyrA gene in multidrug-resistance
Corynebacterium spp. isolates from intravenous sites.

Ramos JN(1)(2), Valadão TB(1)(3), Baio PVP(2)(4), Mattos-Guaraldi AL(2), Vieira
VV(5).

Author information: 
(1)Instituto Nacional de Controle de Qualidade em Saúde (INCQS), Fundação Oswaldo
Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
(2)Laboratório de Difteria e Corinebactérias de Importância Clínica (LDCIC),
Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de
Janeiro, Brazil.
(3)Laboratório Interdisciplinar de Pesquisas Médicas (LIPMED), Instituto Oswaldo 
Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Av. Brasil, 4365, Pavilhão Cardoso Fontes,
10 andar, sala 17, Manguinhos, Rio de Janeiro, RJ, CEP 21040-900, Brazil.
(4)Laboratório Químico-Farmacêutico do Exército (LQFEx), Ministério da Defesa,
Rio de Janeiro, Brazil.
(5)Laboratório Interdisciplinar de Pesquisas Médicas (LIPMED), Instituto Oswaldo 
Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Av. Brasil, 4365, Pavilhão Cardoso Fontes,
10 andar, sala 17, Manguinhos, Rio de Janeiro, RJ, CEP 21040-900, Brazil.
vieira@ioc.fiocruz.br.

The resistance to fluoroquinolones in corynebacteria is due to mutations
occurring in the quinolone-resistance-determining region (QRDR) of the gyrA gene 
encoding the enzyme gyrase A subunit. In recent years we can observe an
increasing number of infections caused by multidrug-resistant Corynebacterium
striatum, Corynebacterium jeikeium and Corynebacterium urealyticum, including
wide range of disorders, such as invasive infections. In this study 14
Corynebacterium spp. isolated from intravenous sites were sequenced and new
combinations of mutations in the QRDR of the gyrA gene were found in C. jeikeium 
and C. urealyticum. Nowadays, no study comparing mutations in this region and the
susceptibility to fluoroquinolones in C. jeikeium and C. urealyticum has been
described. All the isolates that showed double mutation (position 87 and 91) in
the QRDR gyrA gene had high MIC to the fluoroquinolones tested.

DOI: 10.1007/s10482-019-01353-w 
PMCID: PMC7089888
PMID: 31736013 

